TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial

Completed · Phase 3

Conditions studied: Hypertension

In brief

The purpose of this study is to determine the effectiveness of candesartan cilexetil in preventing hypertension in people with high normal blood pressure. Patients will be randomized to either Candesartan or placebo for an initial 2-year period followed by a second 2-year period of placebo for all patients.

Key facts

Study ID
NCT00227318
Run by
AstraZeneca
People needed
1000
Starts
1998-07-01
Expected to finish
2005-10-01
Last updated by the study team
2011-08-30

Who can join

Age: 30 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.